Silence Therapeutics plcSLN
Price (close)
$11.22
Market cap
$697.4M
P/E
—
Revenue (TTM)
$615,000
Net income
-$60.0M
Dividend yield
—
1-year total return
124.4%
Net margin
-9748.5%
Revenue growth
-97.7%
Debt / equity
—
What Silence Therapeutics plc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $21.7M | $31.6M | $43.3M | $559,000 |
| Net income | — | — | -$50.3M | -$54.2M | -$45.3M | -$88.6M |
| Free cash flow | — | — | -$57.2M | -$49.5M | -$67.9M | -$62.3M |
More on SLN.
- Silence Therapeutics plc summary
- Silence Therapeutics plc financial statements
- Silence Therapeutics plc key metrics
- Silence Therapeutics plc health scores and style box
- Silence Therapeutics plc earnings
- Silence Therapeutics plc dividends
- Silence Therapeutics plc valuation
- Silence Therapeutics plc ownership and insiders
- Silence Therapeutics plc peers
Figures from Silence Therapeutics plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.